8:38 AM ET
8-K
Business Update
Moleculin Biotech Business Update
Moleculin Biotech announced the grant of Australian Patent No. 2020303572, which covers the preparation of preliposomal Annamycin lyophilizate. The patent was granted jointly to Moleculin and The Board of Regents of The University of Texas System, strengthening the company's international intellectual property portfolio for its lead drug candidate, Annamycin.
- Counterparty
- The Board of Regents of The University of Texas System